Foundation for Mitochondrial Medicine - Supporting Mitochondrial Disease Research and Treatments

FUNDING THE CURES

Alzheimer’s Drug Discovery Foundation and Foundation for Mitochondrial Medicine Partner to Support Novel Research for Mitochondrial-Directed Therapies

Research could lead to development of new therapies to treat a variety of mitochondrial diseases, including Autism, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease

The Alzheimer’s Drug DiscoveryFoundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM) announced today that they have awarded $200,000 in funding to James Bennett, M.D, Ph.D. to further research gene therapy of mitochondrial protein in the brains of mice with experimental Alzheimer’s disease. Bennett is studying rhTFAM, a novel human mitochondrial protein shown to increase mitochondrial function in cell and animal models. The protein has shown to restore memory function of aged mice while increasing mitochondrial function in brains, suggesting it has great potential to do the same in humans with impaired cognition and early Alzheimer’s disease.

FMM supports the development of the most promising research and treatments of the many forms of mitochondrial disease. Mitochondrial dysfunction is a core element in common neurodegenerative and neurological diseases.

MAKE THE CONNECTIONS: 1-in-2500 people have mitochondrial disease. And a cure for this disease could impact cures for Autism, Parkinson’s disease, Alzheimer’s disease, Lou Gehrig disease, and muscular dystrophy. And it’s this web of complexity and connectivity that makes mitochondrial medicine research valuable to so many.

WHY GIVE: The Foundation for Mitochondrial Medicine’s mission is to support the development of the most promising research and treatments of the many forms of mitochondrial disease. Your donation means momentum to accelerate entry into the clinical trial phases, which will in turn propel mitochondrial disease research faster toward the cures.

CONNECT WITH US: For the latest updates, join our social networks, learn more about Hope Flies, our signature fundraising program, sign up for our mailing list and subscribe to our blog.

Alzheimer’s Drug Discovery Foundation and Foundation for Mitochondrial Medicine Partner to Support Novel Research for Mitochondrial-Directed Therapies

Research could lead to development of new therapies to treat a variety of mitochondrial diseases, including Autism, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease ATLANTA and Read more →
Breast Cancer and Mitochondrial Disease

A reduction in mitochondrial DNA (mtDNA) content leads to more aggressive forms of breast cancer, according to researchers from the University of Pennsylvania. The study, Read more →
Accelerating Medicines Partnership Brings New Opportunities for Drug Discovery

It is very exciting to see the latest announcement from the NIH which represents a new strategy to combine forces and funds of three significant Read more →